Peter Crock

CEO - Cann Group Limited, Chair - Medicinal Cannabis Industry Australia


Drawing on nearly three decades experience at global agribusiness Nufarm (ASX: NUF), and as the founding Chairman of MCIA, Cann Group’s CEO Peter Crock is shaping the future of the medicinal cannabis industry in Australia. With Peter at the helm and working closely with an experienced board of directors, Cann Group (ASX:CAN) received the first commercial cultivation licence in Australia, and was the first medicinal cannabis company to successfully list via an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX), raising AUD$13.5million.

To accelerate its growth, Cann Group has completed subsequent capital raisings totalling more than AUD$125m, which has enabled the advancement of its’ most ambitious project to date; a controlled environment, automated production facility which will be capable of producing up to 70,000kg of medicinal cannabis products per year when at full capacity.

With deep knowledge and experience in the areas of marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.

In chairing the MCIA, Australia’s peak industry body for medicinal cannabis, Peter is well versed in the management of regulatory framework in both Australia, and abroad.

Creating Sustainable and Responsible Value Chains
3/4/20 11:45 am
Back to program
Back to Speakers

Cann Group Limited

Established in 2014, Cann Group is an Australian-based leader in medicinal cannabis with a focus on local cultivation and manufacture of GMP medical products.
Read more
Join Us!

Register your interest to attend and stay up to date with our latest news.